Clinical and preclinical studies presented at the Keystone Symposium on Arthritis, Related Diseases, and Cytokines.
Topics include treatment of multiple sclerosis (MS) with T cell receptor (TCR) peptides, rheumatoid arthritis (RA) with IL-1ra, IL-2 toxin conjugate, or antibodies to TNF, to CD4, or to ICAM-1, sepsis and five other diseases with IL-1ra, and treatment of experimental animal diseases with soluble receptors, IL-12, TGF-beta2, or small molecule antagonists of cytokines.
Ralph
P
P
Department of Immunology, Genentech, Inc., South San Francisco, CA 94080.
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D016207:Cytokines / Q000276:immunology / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006801:Humans; D007167:Immunotherapy; D009103:Multiple Sclerosis / Q000628:therapy*; D010446:Peptide Fragments / Q000627:therapeutic use; D011948:Receptors, Antigen, T-Cell; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000628:therapy*
D000906:Antibodies; D016207:Cytokines; D010446:Peptide Fragments; D011948:Receptors, Antigen, T-Cell; D011994:Recombinant Proteins